HCW Biologics Inc. Current Liabilities
HCW Biologics Inc. (HCWB) had Current Liabilities of $18.65 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $18.65M.
- 2026-03-31: Liabilities, Current $19.96M.
- 2025-12-31: Liabilities, Current $21.06M.
- 2025-09-30: Liabilities, Current $26.86M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $18.65M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $19.96M 10-Q/A · filed 2026-08-14 |
| 2025-12-31 | $21.06M 10-Q/A · filed 2026-08-14 |
| 2025-09-30 | $26.86M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $26.85M 10-Q · filed 2025-08-18 |
| 2025-03-31 | $27.14M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $29.63M 10-K · filed 2026-03-31 |
| 2024-09-30 | $30.06M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $23.22M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $13.41M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $8.75M 10-K · filed 2025-03-28 |
| 2023-09-30 | $5.42M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $4.54M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $4.52M 10-Q/A · filed 2023-08-10 |
| 2022-12-31 | $2.96M 10-K/A · filed 2024-05-15 |
| 2022-09-30 | $2.29M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $1.14M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.42M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $2.32M 10-K · filed 2023-03-28 |
| 2021-09-30 | $2.39M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $4.17M 10-Q · filed 2021-08-13 |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |